Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae

British Journal of Pharmacology

Volumn 119, Issue 6, 1996, Pages 1145-1148

  Van't Veen, Annemarie ^a   Mouton, Johan W ^a   Gommers, Diederik ^a   Lachmann, Burkhard ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Antibiotics; Bacterial pneumonia; Drug carrier; Pulmonary surfactant; Tobramycin; Tracheal instillation

Indexed keywords

ANTIBIOTIC AGENT; DRUG CARRIER; LUNG SURFACTANT; MSE 110; TOBRAMYCIN SULFATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL PNEUMONIA; CONTROLLED STUDY; DRUG EFFICACY; INTRATRACHEAL DRUG ADMINISTRATION; KLEBSIELLA PNEUMONIAE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL RATE;

EID: 0029903386     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb16016.x     Document Type: Article

References (23)

1. AUTEN, R.L., NOTTER, R.H., KENDIG, J.W., DAVIS, J.M. & SHAPIRO, D.L. (1991). Surfactant treatment of full-term new-borns with respiratory failure. Pediatrics, 87, 101-107.
2. BRAIN, J.D., KNUDSON, D.E., SOROKIN, S.P. & DABIS, M.A. (1976). Pulmonary distribution of particles given by intratracheal instillation or by aerosol inhalation. Environ. Res., 11, 13-33.
3. BROWN, R.B., KRUSE, J.A., COUNTS, G.W., RUSSELL, J.A., CHRISTOU, N.V. & SANDS, M.L. (1990). Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia. Antimicrob. Agents Chemother., 34, 269-272.
4. DEMAEYER, P., AKODAD, E.M., GRAVET, E., SCHIETECAT, P., VAN VOOREN, J.P., DROWART, A., YERNAULT, J.C. & LEGROS, F.J. (1993). Disposition of liposomal gentamicin following intrabronchial administration in rabbits. J. Microencapsul., 10, 77-88.
5. EIJKING, E.P., VAN DAAL, G.J., TENBRINCK, R., LUIJENDIJK, A., SLUITERS, J.F., HANNAPPEL, E. & LACHMANN, B. (1991). Effect of surfactant replacement on Pneumocystis carinii pneumonia in rats. Intensive Care Med., 17, 475-478.
6. GOMMERS, D. & LACHMANN, B. (1993). Surfactant therapy: does it have a role in adults? Clin. Intensive Care, 4, 284-295.
7. GOMMERS, D., VILSTRUP, C., BOS, J.A.H., LARSSON, A., WERNER, O., HANNAPPEL, E. & LACHMANN, B. (1993). Exogenous surfactant therapy increases static lung compliance and cannot be assessed by measurements of dynamic compliance alone. Crit. Care Med., 21, 567-574.
8. GORTNER, L., POHLANDT, F. & BARTMANN, P. (1990). Wirkung eines bovinen surfactant bei sehr kleinen fruhgeborenen mit konnataler pneumonie. Monatsschr. Kinderheilkd., 138, 274-278.
9. GÜNTHER, A., SIEBERT, C., SCHMIDT, R., ZIEGLER, S., GRIMMINGER, F., YABUT, M., TEMMESFELD, B., WALMRATH, D., MORR, H. & SEEGER, W. (1996). Surfactant alterations in severe pneumonia, acute respiratory distress syndrome and cardiogenic lung edema. Am. J. Respir. Crit. Care Med., 153, 176-184.
10. HARMS, K. & HERTING, E. (1994). Successful surfactant replacement therapy in two infants with ARDS due to chlamydial pneumonia. Respiration, 61, 348-352.
11. ILOWITE, J.S., GORVOY, J.D. & SMALDONE, G.C. (1987). Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am. Rev. Respir. Dis., 136, 1445-1449.
12. KHARASCH, V.S., SWEENEY, T.D., FREDBERG, J., LEHR, J., DAMOKOSH, A.I., AVERY, M.A. & BRAIN, J.D. (1991). Pulmonary surfactant as a vehicle for intratracheal delivery of technetium sulfur colloid and pentamidine in hamster lungs. Am. Rev. Respir. Dis., 144, 909-913.
13. LACHMANN, B. & GOMMERS, D. (1993). Is it rational to treat pneumonia with exogenous surfactant? Eur. Respir. J., 6, 1437-1438.
14. LIU, M., WANG, L., LI, E. & ENHORNING. G. (1991). Pulmonary surfactant will secure free airflow through a narrow tube. J. Appl. Physiol., 71, 742-748.
15. MIKAWA, K., MAEKAWA, N., NISHINA, K., TAKAO, Y., YAKU, H. & OBARA, H. (1993). Selective intrabronchial instillation in a patient with pneumonia: a preliminary report. Eur. Respir. J., 6, 1563-1566.
16. MUKHOPADHYAY, S., STADDON, G.E., EASTMAN, C., PALMER, M., DAVIES, E.R. & CARSWELL, F. (1994). The quantitative distribution of nebulized antibiotic in the lung in cystic fibrosis. Respir. Med., 88, 203-211.
17. OMRI, A., BEAULAC, C., BOUHAJIB, M., MONTPLAISIR, S, SHARKAWI, M. & LAGACE, J. (1994). Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. Antimicrob. Agents Chemother., 38, 1090-1095.
18. TOUW, D.J., BRIMICOMBE, R.W., HUDSON, M.E., HEIJERMAN, H.G.M. & BARKER, W. (1995). Inhalation of antibiotics in cystic fibrosis. Eur. Respir. J., 8, 1594-1604.
19. VALCKE, Y.J. & PAUWELS, R.A. (1991). Pharmacokinetic evaluation of tobramycin in the alveolar lining fluid of the rat after endotracheal administration. Am. Rev. Respir. Dis 144, 1199-1201.
20. VAN DAAL, G.J., BOS, J.A.H., EIJKING, E.P., GOMMERS, D., HANNAPPEL, E. & LACHMANN, B. (1992). Surfactant replacement therapy improves pulmonary mechanics in end-stage influenza A pneumonia in mice. Am. Rev. Respir Dis 145 859-863.
21. VAN DAAL, G.J., SO, K.L., GOMMERS, D., EIJKING, E.P., FIEVEZ, R.B., SPRENGER, M.J., VAN DAM, D.W. & LACHMANN, B. (1991). Intratracheal surfactant administration restores gas exchange in experimental adult respiratory distress syndrome associated with viral pneumonia. Anesth. Analg., 72, 589-595.
22. VAN'T VEEN, A., GOMMERS, D., MOUTON, J.W., KLUYTMANS, J.A.J.W., KRIJT, E.J. & LACHMANN, B. (1996). Exogenous pulmonary surfactant as a drug delivering agent; influence of antibiotics on surfactant activity. Br. J. Pharmacol., 118, 595-598.
23. VAN'T VEEN, A., MOUTON, J.W., GOMMERS, D., KLUYTMANS, J.A.J.W., DEKKERS, P. & LACHMANN, B. (1995). Influence of pulmonary surfactant on in vitro bactericidal activities of amoxicillin, ceftazidime, and tobramycin. Antimicrob. Agents Chemother., 39, 329-333.